Medtronic’s Next-Gen Hybrid Closed Loop System

medtronic logo.jpg

Medtronic's next-gen hybrid closed loop system will be the Minimed 780G, designed to help patients enjoy greater freedom and less burdens. Currently, the 780G is being studied in an in-home trial with 350 adult and pediatric patients with type 1 diabetes participating, using the device over a three-month period. The in-home study is estimated to be completed in January of 2020, with the results presented in July, 2020.

What should you expect from the new Medtronic system?

  • New vertical "modern" look

  • Automatic correction bolusing

  • A new algorithm, that according to Medtronic is more accurate and reliable

  • A function to automatically adjust for missed meals

  • Adjustable target range, down to 100 mg/dL

  • Option for remote software updates

  • Bluetooth connectivity

Stay tuned for a launch date and other news on the Minimed 780G!